Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
about
Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and managementCoronary microvascular dysfunction, microvascular angina, and treatment strategies.Coronary microvascular dysfunction in women: an overview of diagnostic strategiesCardiovascular Disease in Women: Clinical Perspectives.Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: the missing piece in the puzzle of their increased cardiovascular risk?The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in WomenCoronary microvascular dysfunction: an updateCardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation.Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.Hypothyroidism Is Associated With Coronary Endothelial Dysfunction in Women.Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD.Acetylcholine versus cold pressor testing for evaluation of coronary endothelial functionMyocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in womenPrior myocardial infarction is associated with coronary endothelial dysfunction in women with signs and symptoms of ischemia and no obstructive coronary artery disease.Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software.Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunctionEffect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients With Angina in the Absence of Obstructive Coronary Artery Disease.Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease.Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation.International standardization of diagnostic criteria for vasospastic angina.Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve.Advanced Imaging and Diagnostic Methods in the Assessment of Suspected Ischemic Heart Disease in Women.Gender-specific research for emergency diagnosis and management of ischemic heart disease: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup.Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests.First-pass myocardial perfusion MRI with reduced subendocardial dark-rim artifact using optimized Cartesian sampling.Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.Long-term outcomes of a Caucasian cohort presenting with acute coronary syndrome and/or out-of-hospital cardiac arrest caused by coronary spasm.Mental stress peripheral vascular reactivity is elevated in women with coronary vascular dysfunction: Results from the NHLBI-sponsored Cardiac Autonomic Nervous System (CANS) study.Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.Inverse association of MRI-derived native myocardial T1 and perfusion reserve index in women with evidence of ischemia and no obstructive CAD: A pilot study
P2860
Q26830836-A2ED17F2-81DE-4BE0-87D6-1D1DCD58AF63Q26861073-150B9214-077D-4085-99FC-338DC702885EQ27024500-E1BB7833-BFB3-4BA3-904C-0C540E71A1EEQ30743765-EB17C31E-D283-4C19-9C7D-934E3266166EQ33359341-6CFF6952-B63A-465D-9FB5-7BA16A78F199Q33917513-CDB8D805-E67F-45A3-9983-BAFC1FE5B462Q34658569-F063CBF8-D84E-4C68-AA4A-18B5EAC4B237Q35222305-672832A0-74F3-4617-BC0B-4CC666A173C4Q35581383-3AE153D5-D36D-4F91-84AC-19440FF03184Q36141677-C26F575B-E7CA-4822-A633-3B6DE3FD5526Q36247712-18E0A2AC-6AED-4C24-B83A-6029BE3130FDQ36282922-23A3A440-95C4-4B7D-B824-C2209D7A32AEQ36895814-68BC12BF-DF72-49A9-B322-77EFC2A10402Q37123907-4C74437F-8796-452F-B4A9-D2AEEA24920DQ37339320-60799C29-F0E9-4643-896A-4069A531DBE0Q37339431-2C4ADE75-E122-49AA-8525-178E098E0C6AQ37625185-9E8EAAD9-541D-4BA1-A7FD-70BF0F57BC56Q37629093-F216947D-2607-46ED-B776-65DBF45C2770Q38538168-33CF62DC-5037-4E92-A478-9C1A6C1F37C3Q38561305-BBBF1705-4A70-4773-BB04-1E0406429F35Q38671970-FEC52894-3082-45D3-B4EE-18A7A24C1C45Q38904539-F3D83A89-9393-4DDC-9522-170CD54E52F1Q39095620-EC3878AC-1FEF-4738-A910-3471FBED1EA5Q39176512-1BCEFCE1-9718-4487-919A-3462806880CEQ39304682-86F5BCFD-5989-4365-80AC-2EE5B2E31C97Q39482720-3BC5B5F7-D679-4EB6-8F9D-228A6D340E8DQ47171821-DE3C50EB-F939-4787-ACFA-C32B6FE50B05Q47318143-9A5684D9-E694-4692-A6FE-44BEA1F91C1DQ47580858-EC63F49A-A461-49AF-A31E-4A02D8239786Q48582664-2B02DD75-467D-417C-8CBF-AB4A3A3B5542Q49832321-B64EE234-A076-4C02-B04F-4D6F5BE0C2C6Q56761527-F5FC1927-D95D-4F66-8945-BD7054FB4449
P2860
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Safety of coronary reactivity ...... ia Syndrome Evaluation) study.
@ast
Safety of coronary reactivity ...... ia Syndrome Evaluation) study.
@en
Safety of coronary reactivity ...... from the NHLBI-sponsored WISE
@nl
type
label
Safety of coronary reactivity ...... ia Syndrome Evaluation) study.
@ast
Safety of coronary reactivity ...... ia Syndrome Evaluation) study.
@en
Safety of coronary reactivity ...... from the NHLBI-sponsored WISE
@nl
prefLabel
Safety of coronary reactivity ...... ia Syndrome Evaluation) study.
@ast
Safety of coronary reactivity ...... ia Syndrome Evaluation) study.
@en
Safety of coronary reactivity ...... from the NHLBI-sponsored WISE
@nl
P2093
P2860
P1476
Safety of coronary reactivity ...... ia Syndrome Evaluation) study.
@en
P2093
B Delia Johnson
Babak Azarbal
Barry Sharaf
Bruce Samuels
C Noel Bairey Merz
Carl J Pepine
Chrisandra Shufelt
Eileen Handberg
George Sopko
P2860
P304
P356
10.1016/J.JCIN.2012.01.023
P50
P577
2012-06-01T00:00:00Z